Nearly six years after canceling IPO, Gelesis goes public via SPAC

For the second time in six years, weight loss-focused company Gelesis Inc. has eschewed the IPO route. But this time, it’s still planning to go public — just via a merger with a special-purpose acquisition company that values the company at $1.3 billion.